Financhill
Back

Sarepta Therapeutics Vs. AbbVie Industry Stock Comparison

Sell
42

SRPT
Sarepta Therapeutics

Last Price:
$18.20
Seasonality Move:
17.08%
Buy
60

ABBV
AbbVie

Last Price:
$190.75
Seasonality Move:
3.46%
Sell
42
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $17.71. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
AbbVie (ABBV) is a Buy

Is AbbVie a Buy, Sell or Hold?

  • The current AbbVie [ABBV] share price is $189.99. The Score for ABBV is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $17.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

ABBV Stock Price Chart

What is AbbVie's stock price today?

  • The AbbVie share price today is $189.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.88 Sell
Relative Strength Index (14 RSI): 20.93 Sell
Chaikin Money Flow: -284712 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.01 - 39.83) Sell
Bollinger Bands (100): (32.22 - 93.14) Sell

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 55.85 Buy
Chaikin Money Flow: 3087554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (184.54 - 189.82) Buy
Bollinger Bands (100): (181.02 - 204.06) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.07 Sell
20-day SMA: 27.93 Sell
50-day SMA: 39 Sell
200-day SMA: 92.52 Sell
8-day EMA: 19.21 Sell
20-day EMA: 25.55 Sell
50-day EMA: 38.74 Sell
200-day EMA: 80.29 Sell

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 185.59 Buy
20-day SMA: 187.6 Buy
50-day SMA: 186.41 Buy
200-day SMA: 188.22 Buy
8-day EMA: 186.5 Buy
20-day EMA: 186.72 Buy
50-day EMA: 187.49 Buy
200-day EMA: 186.06 Buy

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.86 per share, a decrease this year of $5.90 per share, and an increase next year of $5.54 per share.

AbbVie Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $1.88 per share, an increase this year of $2.07 per share, and an increase next year of $1.72 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

AbbVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):